Jo Evans, 39, said her four-year-old son Brody-Jac was mobbed by a colony of honey bees and was stung dozens of times across ...

Incyte’s pipeline updates on Monday bring into question the value of its $750 million Escient acquisition in April 2024—and ...

U.S. President-elect Donald Trump's search for a Treasury secretary is widening after it stalled over the weekend, and he is ...

The FDA is set to give its decision on SNY and REGN's sBLA for Dupixent for chronic spontaneous urticaria on April 18, 2025.

Jasper Therapeutics faces financial challenges but strong buy ratings. Read why JSPR stock is poised for growth amid risks ...

There are dermatologists who don’t have much training in vulvar dermatology, and a lot of gyns don’t get as much training” as ...

A study found that people who live in places with high levels of air pollution are more likely to have eczema.

US FDA accepts for review the resubmission of sBLA for Dupixent to treat chronic spontaneous urticaria: Paris Monday, November 18, 2024, 11:00 Hrs [IST] The US Food and Drug Admin ...

When treating mild allergic reactions, allergists and pediatricians prefer children’s Zyrtec over children’s Benadryl. OTC ...

Paris: Sanofi and Regeneron has announced that the US Food and Drug Administration (FDA) has accepted for review the ...

A network of Dak Bungalows & rest houses offered lodging to the ever-mobile British officials in colonial India ...